Business Description
Jeil Pharma Holdings Inc
ISIN : KR7002620003
Compare
Compare
Traded in other countries / regions
002620.Korea IPO Date
1988-01-20Description
Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | -4.3 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.97 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.8 | |||||
| 3-Year EBITDA Growth Rate | -39.9 | |||||
| 3-Year FCF Growth Rate | 25.1 | |||||
| 3-Year Book Growth Rate | -7.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.18 | |||||
| 9-Day RSI | 47.09 | |||||
| 14-Day RSI | 45.89 | |||||
| 6-1 Month Momentum % | -14.73 | |||||
| 12-1 Month Momentum % | -28.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.01 | |||||
| Quick Ratio | 0.66 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 84.45 | |||||
| Days Sales Outstanding | 84.1 | |||||
| Days Payable | 99.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.63 | |||||
| 3-Year Dividend Growth Rate | -10.6 | |||||
| Forward Dividend Yield % | 0.63 | |||||
| 5-Year Yield-on-Cost % | 0.42 | |||||
| Shareholder Yield % | -0.21 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.08 | |||||
| Operating Margin % | -1.81 | |||||
| Net Margin % | -5.33 | |||||
| FCF Margin % | 1.01 | |||||
| ROE % | -12.62 | |||||
| ROA % | -4.67 | |||||
| ROIC % | -2.13 | |||||
| ROC (Joel Greenblatt) % | -17.09 | |||||
| ROCE % | -10.18 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.16 | |||||
| PB Ratio | 0.37 | |||||
| Price-to-Tangible-Book | 0.45 | |||||
| Price-to-Free-Cash-Flow | 15.42 | |||||
| Price-to-Operating-Cash-Flow | 7.7 | |||||
| EV-to-EBIT | -6.67 | |||||
| EV-to-EBITDA | -9.25 | |||||
| EV-to-Revenue | 0.42 | |||||
| EV-to-FCF | 28.67 | |||||
| Price-to-Projected-FCF | 1.02 | |||||
| Price-to-Median-PS-Value | 0.31 | |||||
| Earnings Yield (Greenblatt) % | -15 | |||||
| FCF Yield % | 6.48 | |||||
| Forward Rate of Return (Yacktman) % | -93.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jeil Pharma Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 778,787.043 | ||
| EPS (TTM) (â‚©) | -2702 | ||
| Beta | 0.51 | ||
| Volatility % | 12.01 | ||
| 14-Day RSI | 45.89 | ||
| 14-Day ATR (â‚©) | 362.590643 | ||
| 20-Day SMA (â‚©) | 8021.5 | ||
| 12-1 Month Momentum % | -28.99 | ||
| 52-Week Range (â‚©) | 7200 - 12380 | ||
| Shares Outstanding (Mil) | 15.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jeil Pharma Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jeil Pharma Holdings Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jeil Pharma Holdings Inc Frequently Asked Questions
What is Jeil Pharma Holdings Inc(XKRX:002620)'s stock price today?
The current price of XKRX:002620 is â‚©7920.00. The 52 week high of XKRX:002620 is â‚©12380.00 and 52 week low is â‚©7200.00.
When is next earnings date of Jeil Pharma Holdings Inc(XKRX:002620)?
The next earnings date of Jeil Pharma Holdings Inc(XKRX:002620) is .
Does Jeil Pharma Holdings Inc(XKRX:002620) pay dividends? If so, how much?
The Dividend Yield %  of Jeil Pharma Holdings Inc(XKRX:002620) is 0.63% (As of Today), Highest Dividend Payout Ratio of Jeil Pharma Holdings Inc(XKRX:002620) was 0.37. The lowest was 0.05. And the median was 0.08. The  Forward Dividend Yield % of Jeil Pharma Holdings Inc(XKRX:002620) is 0.63%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers